Tag Archives: biotech

Top Five Mistakes in Clinical Protocol Design

By Lisa R. Sanders, Ph.D., R.A.C., Sr. Clinical Scientist II at Cato Research Almost a Holy Grail for the pharma/biotech world, the perfect clinical study protocol requires no amendments, collects only the data needed for the planned analysis, is fully … Continue reading

Posted in Clinical Trials, Drug Development | Tagged , , , , | Comments Off on Top Five Mistakes in Clinical Protocol Design

AMP’d Up Search for Biomarkers

By Kathy A. Grako, Ph.D., PMP, CCRP, Senior Clinical Strategy Scientist In February the United States government announced a unique triad brought together to “accelerate the development of life saving drugs and to help identify new treatments and cures for … Continue reading

Posted in Clinical Trials, Medical Research, Rare Diseases | Tagged , , , , | Comments Off on AMP’d Up Search for Biomarkers

The ILSI-BioMed Israel Conference Continues to Grow

The 11th annual ILSI-BioMed 2012 Conference, also known as National Life Science and Technology Week, was held in Tel Aviv, Israel on 21-23 May 2012. Throughout the many years of attendance, we’ve seen exciting growth in diverse fields of technology … Continue reading

Posted in Conferences and Meetings, Venture Capital | Tagged , , , , , , , , | Comments Off on The ILSI-BioMed Israel Conference Continues to Grow

New FDA Guidances Released in May 2012

Here’s a list of the  guidances released by FDA in April 2012, compiled by Cato Research Scientist Elinore Mercer, Ph.D. Pediatric Information for X-ray Imaging Device Premarket Notifications (Draft) S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals Pathologic Complete Response in … Continue reading

Posted in FDA, Industry News | Tagged , , , , , , , , , , , , | Comments Off on New FDA Guidances Released in May 2012

Cato Research Canada Celebrates Two Decades of Success in the Drug Development Industry

Over the past 5 years, the life sciences industry throughout Canada, and especially in Québec, has been extensively challenged. Capitalizing on strong relationships built over years with clients and partners has helped Cato Research continue to provide excellent services and weather the industry’s roller coaster ride. On 03 May 2012, Cato Research Canada will celebrate its 20th anniversary with a celebratory wine tasting. You are invited to join us and other industry representatives to talk about the changing climate for pharmaceutical and biotechnology companies in Canada. Continue reading

Posted in Industry News | Tagged , , , , , , , , , , | Comments Off on Cato Research Canada Celebrates Two Decades of Success in the Drug Development Industry